• Yues International issued a supplemental clarification on delays in using rights issue proceeds disclosed in its 2025 annual report.
• Revised full-utilization deadline moved to on or before Dec. 31, 2026 for HK$19.4 million unspent general working capital proceeds.
• Goat milk project spending slowed; HK$15.3 million remained unutilized at Dec. 31, 2025, with the same Dec. 31, 2026 deadline.
• Board broadened permitted use of about HK$15.26 million from the goat milk plan to the wider “big health” business from Apr. 13, 2026.
• Working-capital usage detailed: HK$8.2 million from the rights issue, HK$4.8 million from a reallocated 2023 placing, mainly admin costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yues International Holdings Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260910-12327930), on September 10, 2026, and is solely responsible for the information contained therein.